. Author manuscript; available in PMC: 2020 Jul 1.

Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):345–354. doi: 10.1097/QAI.0000000000002043

Table 3.

Demographic and clinical characteristics of the three HIV+ Caine subgroups

	HIV+ Caine 0 (n=20)	HIV+ Caine 1 (n=22)	HIV+ Caine 2 (n=14)	p value
Age	49.7 ± 6.3	53.3 ± 9.1	55.2 ± 7.3	ns
Education (years)	14.8 ± 1.5	13.5 ± 3.2	12.6 ± 2.1	<.05 [HIV+ Caine 2 <HIV+ Caine 0]
Beck Depression Inventory-II (BDI-II) Score ^*	8.5 ± 7.0; 9.0	9.5 ± 8.8; 7.5	12.2 ± 9.5; 9.0	ns
Approximate Age of HIV Onset	33.6 ± 9.0	38.5 ± 9.0	34.9 ± 10.3	ns
Disease Duration (years)	16.0 ± 8.4	14.7 ± 8.2	20.4 ± 7.1	ns
Log Viral Load^a	2.0 ± 1.0	2.1 ± 1.2	2.2 ± 1.3	ns
CD4 Count^*^b	701.7 ± 273.4; 711.0	582.7 ± 289.4; 538.5	527.3 ± 283.7; 519.0	ns
Lifetime Alcohol Consumption (kg)^*	83.8 ± 84.3; 69.5	72.0 ± 75.8; 50.0	85.9 ± 80.8; 79.5	ns
Hepatitis C^c
Yes	2	8	6	.06, Χ²=5.65
No	18	13	8	.06, Χ²=5.65
AIDS^c
Yes	8	14	6	.30, Χ²=2.38
No	11	8	8	.30, Χ²=2.38
Drug History
Yes	11	10	7	.83, Χ²=.38
No	9	12	7	.83, Χ²=.38

Mean ± SD; median

ns=not significant

Collected on 17 HIV+ Caine 0, 21 HIV+ Caine 1, and 13 HIV+ Caine 2

Collected on 19 HIV+ Caine 0, 22 HIV+ Caine 2, and 13 HIV+ Caine 2

Collected on 55 HIV+ individuals